31.08.2023  21:59:59 Zm. - Wolumen Bid01:50:00 Ask01:50:00 Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
39,7500USD - 31,37 mln
Obrót: 336,35 mln
39,2900Wolumen Bid: - 39,9000Wolumen Ask: - 2,08 mldUSD - 50,96

Opis działalności

NuVasive is a global medical device company focused on transforming spine surgery by empowering surgeons with technology to approach procedures in the least disruptive way possible and restore the vitality of life for those that suffer from debilitating spinal conditions. Through its minimally invasive, procedurally-integrated solutions, the Company is expanding the boundaries of modern healthcare with technologies and surgeon training designed to provide reproducible and clinically-proven surgical outcomes that are redefining the success factors of spine surgery like never before. Addressing a variety of pathologies up and down the spine, from complex spinal deformity to degenerative spinal conditions, NuVasive's highly differentiated solutions include access instruments, implantable hardware and increasingly expert software systems like its game-changing iGA™ surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. NuVasive believes its integrated approach and expertise can fundamentally evolve spine care by delivering improved patient experiences, and better economics for healthcare systems.
 

Zarząd & Rada nadzorcza

CEO
J. Christopher Barry
Zarząd
Matthew K. Harbaugh, Aviva McPherron, Brent Boucher, Dale Wolf, Kyle Malone, Lucas Vitale, Massimo Calafiore, Michael Farrington, Nathaniel Sisitsky, Sean Freeman
Rada nadzorcza
Daniel J. Wolterman, Amy Belt Raimundo, Donald J. Rosenberg, J. Christopher Barry, John A. DeFord, Leslie V. Norwalk, R. Scott Huennekens, Robert F. Friel, Siddhartha Kadia, Vickie L. Capps
 

Dane firmy

Nazwa: NuVasive Inc.
Adres: 7475 Lusk Boulevard,San Diego, California 92121, USA
Telefon: +1-858-909-1800
Fax: +1-800-475-9134
E-mail: info@nuvasive.com
Internet: www.nuvasive.com/
Przemysł: Służba zdrowia
Sektor: Produkty Medyczne
Podsektor: Zaawansowane Urządzenia Medyczne
Koniec roku finansowego: 31.12
Free float: 60,20%
Data IPO: -

Relacje inwestorskie

Nazwa: Juliet C. Cunningham
Telefon: +1-858-458-2240
Fax: -
E-mail: investorrelations@nuvasive.com

Główni akcjonariusze

Freefloat
 
60,20%
Wellington Management Company LLP
 
13,00%
BlackRock, Inc.
 
12,20%
The Vanguard Group
 
9,40%
The Hartford Mutual Funds, Inc.
 
5,20%